Clinical Trial Detail

NCT ID NCT03123055
Title A Study of B-701 in Combination With Atezolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma (U22)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors BioClin Therapeutics, Inc.
Indications

transitional cell carcinoma

Therapies

Atezolizumab + Vofatamab

Age Groups: adult senior

No variant requirements are available.